20 Mar 2024
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218448
29 Sep 2022
// BUSINESS STANDARD
https://www.business-standard.com/article/news-cm/supriya-life-gains-on-securing-cep-for-anti-histamine-therapy-122092900204_1.html
24 Sep 2020
// BUSINESS STANDARD
https://www.business-standard.com/article/markets/granules-india-up-5-on-usfda-approval-for-generic-aleve-pm-tablets-120092500500_1.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213663
27 Aug 2019
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211830
14 Aug 2019
// FDA
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-14-2019-1565765849.pdf